Engineered Exosomes as a Treatment for Alzheimer's Disease
Key claim: Engineered exosomes harvested from young donor blood, tissues, or stem cells produced favorable results in a mouse model of Alzheimer’s disease, while unengineered exosome therapies are already offered via medical tourism.
Abstract
Exosomes are one category of extracellular vesicle secreted by cells, a membrane-wrapped package of molecules, one complex component of the extensive, incompletely mapped communication that takes place constantly between cells. Exosome therapies are conceptually similar to stem cell therapies, an attempt to favorably adjust the behavior of native cells via signaling. While the first exosome therapies are widely available via medical tourism, with a few organizations in the early stages of sponsoring clinical trials to allow use in more regulated regions, the research community is assessing approaches that involve engineering the contents or surface features of exosomes harvested from young donor blood, tissues, or stem cells. The example here is tested in a mouse model of Alzheimer’s disease, producing favorable results. In this study, the […]
Why this matters
Engineered exosomes harvested from young donor blood, tissues, or stem cells produced favorable results in a mouse model of Alzheimer’s disease, while unengineered exosome therapies are already offered via medical tourism.